(E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide

C42H49N11O13S2 — CID 162214974

IUPAC(E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide
SMILESCOCOc1ccccc1/C=C/S(=O)(=O)NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C2OC(C)(C)O[C@H]21.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CNS(=O)(=O)/C=C/c2ccccc2O)[C@H](O)C1O
InChIInChI=1S/C23H28N6O7S.C19H21N5O6S/c1-23(2)35-18-16(10-28-37(30,31)9-8-14-6-4-5-7-15(14)33-13-32-3)34-22(19(18)36-23)29-12-27-17-20(24)25-11-26-21(17)29;20-12-5-7-21-18-15(12)22-10-24(18)19-17(27)16(26)14(30-19)9-23-31(28,29)8-6-11-3-1-2-4-13(11)25/h4-9,11-12,16,18-19,22,28H,10,13H2,1-3H3,(H2,24,25,26);1-8,10,14,16-17,19,23,25-27H,9H2,(H2,20,21)/b9-8+;8-6+/t16-,18+,19?,22-;14-,16+,17?,19-/m11/s1
InChIKeyZTILRZBHWMBWGJ-DGHYGHDZSA-N
MW980.05 g/mol
LogP1.33
Rot. Bonds15

About (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide

(E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide (PubChem CID 162214974) has the molecular formula C42H49N11O13S2 and a molecular weight of 980.05 g/mol. Its IUPAC name is (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide.

Molecular Properties

Compound Name(E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide
PubChem CID162214974
Molecular FormulaC42H49N11O13S2
Molecular Weight980.05 g/mol
Exact Mass979.30
IUPAC Name(E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide
SMILESCOCOc1ccccc1/C=C/S(=O)(=O)NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C2OC(C)(C)O[C@H]21.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CNS(=O)(=O)/C=C/c2ccccc2O)[C@H](O)C1O
InChIInChI=1S/C23H28N6O7S.C19H21N5O6S/c1-23(2)35-18-16(10-28-37(30,31)9-8-14-6-4-5-7-15(14)33-13-32-3)34-22(19(18)36-23)29-12-27-17-20(24)25-11-26-21(17)29;20-12-5-7-21-18-15(12)22-10-24(18)19-17(27)16(26)14(30-19)9-23-31(28,29)8-6-11-3-1-2-4-13(11)25/h4-9,11-12,16,18-19,22,28H,10,13H2,1-3H3,(H2,24,25,26);1-8,10,14,16-17,19,23,25-27H,9H2,(H2,20,21)/b9-8+;8-6+/t16-,18+,19?,22-;14-,16+,17?,19-/m11/s1
InChIKeyZTILRZBHWMBWGJ-DGHYGHDZSA-N
XLogP1.33
TPSA334.76 Ų
H-Bond Donors7
H-Bond Acceptors22
Rotatable Bonds15
Heavy Atoms68
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500980.05
LogP ≤ 51.33
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide?
The IUPAC name of (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide (CID 162214974) is (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide.
What is the SMILES notation for (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide?
The canonical SMILES for (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide is COCOc1ccccc1/C=C/S(=O)(=O)NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C2OC(C)(C)O[C@H]21.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CNS(=O)(=O)/C=C/c2ccccc2O)[C@H](O)C1O.
What is the InChIKey of (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide?
The InChIKey is ZTILRZBHWMBWGJ-DGHYGHDZSA-N. The full InChI is InChI=1S/C23H28N6O7S.C19H21N5O6S/c1-23(2)35-18-16(10-28-37(30,31)9-8-14-6-4-5-7-15(14)33-13-32-3)34-22(19(18)36-23)29-12-27-17-20(24)25-11-26-21(17)29;20-12-5-7-21-18-15(12)22-10-24(18)19-17(27)16(26)14(30-19)9-23-31(28,29)8-6-11-3-1-2-4-13(11)25/h4-9,11-12,16,18-19,22,28H,10,13H2,1-3H3,(H2,24,25,26);1-8,10,14,16-17,19,23,25-27H,9H2,(H2,20,21)/b9-8+;8-6+/t16-,18+,19?,22-;14-,16+,17?,19-/m11/s1.
What are the key properties of (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide?
(E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide has a molecular weight of 980.05 g/mol, XLogP of 1.33, 15 rotatable bonds, 7 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-N-[[(4R,6R,6aS)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl]-2-[2-(methoxymethoxy)phenyl]ethenesulfonamide;(E)-N-[[(2R,3R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(2-hydroxyphenyl)ethenesulfonamide is sourced from PubChem (CID 162214974), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).